What are the risks of investing in ELVN?
E
What are the risks of investing in ELVN?
🦉
Enliven Therapeutics, Inc. (ELVN)
Company Overview
Sector / IndustryHealthcare / Biotechnology
CEORichard A. Fair
Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in...
Key Executives
| Name | Title |
|---|---|
| Anish Patel | Co-Founder & Chief Operating Officer |
| Benjamin Hohl | Chief Financial Officer & Head of Corporate Development |
| Galya D. Blachman | Chief Legal Officer & Head of Business Development |
| Helen Louise Collins | Chief Medical Officer |
| Joseph Lyssikatos | Co-Founder & Chief Scientific Officer |
| Richard A. Fair | CEO, President & Director |
Financial Health
Risk Assessment
Weather Score0/100
RegimeN/A